Articles for Hikma Pharmaceuticals (LSE: HIK)

I think these 2 fast-recovering FTSE 250 pharma growth stocks could make you richer

Harvey Jones says these two FTSE 250 (INDEXFTSE: MCX) stocks are in fine form after a sickly year. More »

Can this year’s biggest FTSE 250 winners keep it going in 2019?

2018 has been a great year for the top FTSE 250 (INDEXFTSE: MCX) stocks. Will 2019 see their strong run continuing? More »

The BT share price soars by 20%. Here’s why I think it could beat the FTSE 100

BT Group plc (LON: BT.A) could offer further growth potential versus the FTSE 100 (INDEXFTSE:UKX). More »

FTSE 100 crash? Is this the best stock to hold in case it happens?

Should you be looking for 'picks-and-shovels' plays in case the FTSE 100 (INDEXFTSE: UKX) is heading for a fall? More »

Is Hikma Pharmaceuticals the hottest growth stock in the FTSE 250?

FTSE 250 (INDEXFTSE: MCX) growth stock Hikma Pharmaceuticals plc (LON: HIK) is up 120% since March. Are there more gains to come? More »

Why I’d buy this FTSE 250 flyer alongside AstraZeneca plc

I reckon there is more to come for investors from this pharmaceutical company and from AstraZeneca plc (LON: AZN). More »

Why is the Burberry share price up 20% so far this year?

Shares in Burberry Group plc (LON:BRBY) are riding high as the luxury fashion house makes good progress on its turnaround. More »

2 super growth stocks I’d buy with £5,000 today

Just £5,000 could help you make a fortune with these super growth stocks. More »

2 cheap growth stocks I’d buy for the long term

These two shares could offer a mix of growth and value in current market conditions. More »

2 FTSE 250 pharma stocks I’d buy today and hold for another five years

Roland Head takes a look at two unusual pharma stocks with long-term growth potential. More »

Provident Financial plc isn’t the only turnaround stock I’m considering buying for my ISA

G A Chester discusses whether Provident Financial plc (LON:PFG) and another fallen growth star are now brilliant recovery buys. More »

Two defensive growth stocks I’d buy and hold for 10 years

These two stocks are struggling today but the future could still be bright. More »

2 turnaround stocks I’d consider buying before 2018

Could these two turnaround stocks beat the market in 2018 and beyond? More »

Are these two beaten-up FTSE 250 turnaround plays buys after today’s results?

Harvey Jones says these FTSE 250 (INDEXFTSE:MCX) stocks could reward further investigation despite patchy results. More »

Why I’d buy this FTSE 250 stock alongside AstraZeneca plc

I think AstraZeneca plc (LON: AZN) pairs well with this FTSE 250 (INDEXFTSE: MCX) player. More »

2 growth stocks for the long run

These two stocks could perform well in future years. More »

2 turnaround stocks that could make you rich

Bilaal Mohamed picks out two battered pharmaceutical stocks that could turn out to be excellent recovery plays. More »

There could be hidden value in these FTSE 250 stocks

G A Chester discusses his two top-value picks from the FTSE 250 (INDEXFTSE:MCX). More »

Why this battered pharma stock could be a top turnaround buy

Roland Head selects his turnaround pick from two of this year's biggest pharma fallers. More »

Hikma Pharmaceuticals plc’s pain could be GlaxoSmithKline plc’s gain

Could ongoing approval issues at Hikma Pharmaceuticals plc (LON: HIK) and rivals help GlaxoSmithKline plc (LON:GSK) preserve its dividend? More »